• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Lung Cancer: Targets and Therapy >Landscape on CT screening for lung cancer in Asia
【24h】

Landscape on CT screening for lung cancer in Asia

机译：亚洲肺癌CT筛查的前景

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Lung cancer remains the leading cause of cancer incidence and mortality worldwide. Approximately 60% of the world’s new cases of lung cancer and deaths from it are expected in Asia in 2018. Currently, lung cancer screening using low-dose computed tomography (LDCT) is recommended for heavy smokers in North America, Europe and some countries in Asia. Tobacco smoking being the major risk factor for lung cancer, but in Asia, lung cancer in never-smokers (LCINS) is also a concern. This paper reviews on lung cancer incidence, mortality, etiology, smoking in Asia, and systematic reviews on LDCT lung cancer screening studies, including ongoing projects and recommendation on lung cancer screening in Asia. Some of the earliest studies of LDCT lung cancer screening worldwide were in Asia. Many countries in Asia have developed LDCT screening studies in various high-risk participants. Currently, there are several ongoing large-scale lung cancer screening trials to evaluate the efficacy of LDCT screening for never-smokers?and light smokers, as well as heavy smokers, and to evaluate the feasibility of population-based LDCT lung cancer screening.
机译：肺癌仍然是全世界癌症发生率和死亡率的主要原因。预计到2018年，亚洲约有60％的全球肺癌新病例及其死亡。目前，建议北美，欧洲和部分国家的重烟民使用低剂量计算机断层扫描（LDCT）进行肺癌筛查。亚洲。吸烟是肺癌的主要危险因素，但在亚洲，从不吸烟者（LCINS）的肺癌也令人担忧。本文回顾了亚洲的肺癌发生率，死亡率，病因，吸烟情况，以及有关LDCT肺癌筛查研究的系统综述，包括正在进行的有关亚洲肺癌筛查的项目和建议。全球最早的LDCT肺癌筛查研究都在亚洲。亚洲许多国家已针对各种高风险参与者开展了LDCT筛查研究。当前，有数项正在进行的大规模肺癌筛查试验，以评估LDCT筛查对不吸烟者，轻烟者和重度吸烟者的疗效，并评估基于人群的LDCT肺癌筛查的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号